David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Hackett Group
HCKT
$276M
| $392K | ﹤0.01% |
15,415
-810
| -5% | -$20.6K |
|
3627
Bahl & Gaynor Small/Mid Cap Income Growth ETF
SMIG
$1.49B
| $391K | ﹤0.01% |
13,541
-13,703
| -50% | -$386K |
|
3628
Global X DAX Germany ETF
DAX
$227M
| $390K | ﹤0.01% |
+8,689
| New | +$365K |
|
3629
Invesco KBW Property & Casualty Insurance ETF
KBWP
$290M
| $390K | ﹤0.01% |
3,178
| – | – |
|
|
THR
3630
DELISTED
Thermon Group Holdings
THR
| $390K | ﹤0.01% |
13,881
+1,142
| +9% | +$30.9K |
|
3631
PUT
Iron Mountain
IRM
$36.1B
| $390K | ﹤0.01% |
3,800
-35,300
| -90% | -$3.33M |
|
3632
Vitamin Cottage Natural Grocers
NGVC
$648M
| $389K | ﹤0.01% |
9,916
+3,360
| +51% | +$156K |
|
3633
CALL
Under Armour
UAA
$2.31B
| $389K | ﹤0.01% |
56,900
| – | – |
|
3634
RPC Inc
RES
$1.37B
| $388K | ﹤0.01% |
81,958
-122,554
| -60% | -$590K |
|
|
ONC
3635
CALL
BeOne Medicines Ltd
ONC
$42.1B
| $387K | ﹤0.01% |
+1,600
| New | +$392K |
|
3636
VanEck Vietnam ETF
VNM
$517M
| $386K | ﹤0.01% |
28,095
+9,832
| +54% | +$125K |
|
3637
iShares Global REIT ETF
REET
$5.08B
| $384K | ﹤0.01% |
15,558
-2,235
| -13% | -$54.2K |
|
3638
uniQure
QURE
$3.29B
| $384K | ﹤0.01% |
+27,531
| New | +$370K |
|
3639
Nexstar Media Group
NXST
$5.74B
| $382K | ﹤0.01% |
+2,211
| New | +$362K |
|
|
DFTX
3640
Definium Therapeutics
DFTX
$5.81B
| $381K | ﹤0.01% |
58,764
-4,485
| -7% | -$29.5K |
|
3641
ARKO Corp
ARKO
$530M
| $381K | ﹤0.01% |
90,062
+76,528
| +565% | +$334K |
|
3642
ADT
ADT
$5.42B
| $377K | ﹤0.01% |
44,563
-3,072,286
| -99% | -$25.2M |
|
3643
Ryder
R
$9.39B
| $377K | ﹤0.01% |
2,372
-5,396
| -69% | -$793K |
|
3644
Great Southern Bancorp
GSBC
$857M
| $376K | ﹤0.01% |
6,399
+1,468
| +30% | +$81.9K |
|
3645
UroGen Pharma
URGN
$2.26B
| $376K | ﹤0.01% |
+27,432
| New | +$263K |
|
3646
Franklin US Mid Cap Multifactor Index ETF
FLQM
$1.59B
| $375K | ﹤0.01% |
6,905
| – | – |
|
3647
POSCO
PKX
$17.7B
| $375K | ﹤0.01% |
7,728
-29,214
| -79% | -$1.34M |
|
3648
Amalgamated Financial
AMAL
$1.46B
| $371K | ﹤0.01% |
11,901
-11,031
| -48% | -$323K |
|
3649
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.9B
| $371K | ﹤0.01% |
8,978
-1,100
| -11% | -$42.6K |
|
3650
Pacer Lunt Large Cap Alternator ETF
ALTL
$91.9M
| $371K | ﹤0.01% |
9,843
| – | – |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.